[1]马春丽,于艺,迟倩慧,等.麻黄附子细辛汤治疗缓慢性心律失常的网络药理学机制[J].西部中医药,2024,37(02):104-110.[doi:10.12174/j.issn.2096-9600.2024.02.20]
　MA Chunli,YU Yi,CHI Qianhui,et al.Mechanism of Mahuang Fuzi Xixin Decoction in Treating Bradyarrhythmia Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2024,37(02):104-110.[doi:10.12174/j.issn.2096-9600.2024.02.20]
点击复制

麻黄附子细辛汤治疗缓慢性心律失常的网络药理学机制

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年02期
页码:
104-110
栏目:
二次研究
出版日期:
2024-02-15

文章信息/Info

Title:
Mechanism of Mahuang Fuzi Xixin Decoction in Treating Bradyarrhythmia Based on Network Pharmacology
作者:
马春丽, 于艺, 迟倩慧, 张蕾, 刘颖
山东中医药大学针灸推拿学院，山东 济南 250300
Author(s):
MA Chunli, YU Yi, CHI Qianhui, ZHANG Lei, LIU Ying
College of Acupuncture and Tuina, Shandong University of Traditional Chinese Medicine, Jinan 250300, China
关键词:
心律失常; 缓慢性; 麻黄附子细辛汤; 网络药理学
Keywords:
bradyarrhythmia; decoction; network pharmacology
分类号:
R541
DOI:
10.12174/j.issn.2096-9600.2024.02.20
文献标志码:
A
摘要:
目的基于网络药理学探讨麻黄附子细辛汤治疗缓慢性心律失常的作用机制。 方法通过TCMSP数据库结合OB、DL、HL检索麻黄附子细辛汤中麻黄、附子、细辛的化学成分和作用靶点，并通过Uniprot数据库将靶点校正为基因名，运用GeneCards数据库获取缓慢性心律失常的相关靶点与基因。通过Venny图将缓慢性心率失常的靶点和药物靶点进行分析，筛选出交集靶点，并借助Cytoscape 3.6.1软件构建化合物靶点相互作用图；根据STRING数据库构建蛋白质相互作用的PPI网络图；利用David数据库对交集靶点进行GO富集分析和KEGG通路富集分析。 结果筛选出麻黄附子细辛汤治疗缓慢性心律失常的36个有效活性成分，关键化合物为槲皮苷和山柰酚；与治疗缓慢性心律失常相关的靶点65个，主要靶点有IL-6、TNF、VEGFA、CXCL8、IL-1B等，主要涉及腺苷酸环化酶激活肾上腺素能受体信号通路、一氧化氮生物合成过程的正向调节、去甲肾上腺素-肾上腺素血管收缩参与全身动脉血压的调节、血管生成的积极调节等生物工程，通过参与TNF、Toll样受体、钙、cGMP-PKG等信号通路治疗缓慢性心律失常。 结论该研究从多角度探索了麻黄附子细辛汤治疗缓慢性心律失常的可能作用机制，认为麻黄附子细辛汤通过多成分、多靶点、多途径治疗缓慢性心律失常，为临床上治疗该病提供了有力的依据。
Abstract:
ObjectiveTo explore the mechanism of Mahuang Fuzi Xixin decoction in treating bradyarrhy-thmia based on network pharmacology. MethodsChemical ingredients and the targets of Mahuang (ephedrae herba), Fuzi (aconiti lateralis radix praeparata) and Xixin (Asari radix et rhizoma) in Mahuang Fuzi Xixin decoction were searched from TCMSP, OB, DL and HL, the targets were corrected to gene names via the Uniprot database, the related targets and genes of bradyarrhythmia were obtained using GeneCards database. The intersection targets were screened after analyzing the targets of the disease and drug targets via Venny diagram, compound-target interaction diagram was built via Cytoscape 3.6.1 software; PPI network was constructed based on STRING database; GO enrichment analysis and KEGG pathway enrichment analysis of the intersection targets were carried out utilizing David database. ResultsAll 36 effective active ingredients of Mahuang Fuzi Xixin Decoction in treating the disease have been screened, and the key compounds are quercetin and kaempferol; there were 65 targets related to the treatment of the disease, and the main ones contained IL-6, TNF, VEGFA, CXCL8 and IL-1B, mainly involving the adrenergic receptor signaling pathway activated by adenylate cyclase, positive regulation of nitric oxide biosynthetic processes, norepinephrine-adrenergic vasoconstriction involved in the regulation of systemic arterial blood pressure, positive regulation of angiogenesis, which could treat the disease through participating in TNF signaling pathway, Toll-like receptor signaling pathway, calcium signaling pathway and cGMP-PKG signaling pathway. ConclusionThe study has been a multifaceted investigation of the potential mechanism of Mahuang Fuzi Xixin decoction in the treatment of bradyarrhythmia, it is believed that the decoction could treat the disease from multi-ingredient, multi-target and multi-way, and it could produce the powerful evidence for clinical treatment of the disease.

相似文献/References:

[1]陈彦文,明海霞,王强,等.岷县当归预适应对大鼠缺血-再灌注心律失常的影响*[J].西部中医药,2013,26(02):15.
　CHEN Yanwen,MING Haixia,WANG Qiang,et al.Effects of MinXian County Angelica Pre-adaptation to the Rats with Ischemia-Reperfusion Arrhythmia[J].Western Journal of Traditional Chinese Medicine,2013,26(02):15.
[2]李舟文,梁益辉,温明达.宁静汤加味治疗室上性心动过速 43 例[J].西部中医药,2014,27(08):59.
[3]张辉,魏丰贤.参仙升脉口服液治疗缓慢性心律失常的Meta分析[J].西部中医药,2015,28(06):69.[doi:2015/6/16 0:00:00]
[4]曲畅,唐靖一△.益气养阴法治疗心律失常的中医用药文献分析[J].西部中医药,2015,28(12):71.
[5]朱久珍.步长稳心颗粒治疗冠心病室性心律失常45例[J].西部中医药,2013,26(12):75.
　ZHU Jiuzheng.BuChang WenXin Granules in Treating 45 Patients Suffering from Ventricular Arrhythmia of Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(02):75.
[6]张华军,史志新.参味复脉汤治疗心律失常80例[J].西部中医药,2014,27(12):62.
[7]李银花.辨证施护对降低食管癌术后患者心律失常及焦虑发生的效果观察[J].西部中医药,2016,29(02):131.
　LI Yinhua.Effects of Syndrome Differentiation and Care on Decreasing the Incidences of Arrhythmia and Anxiety of the Patients after the Operation of Esophageal Cancer[J].Western Journal of Traditional Chinese Medicine,2016,29(02):131.
[8]李雅宁,邰炜彦△,王璟,等.养心定悸胶囊治疗扩张型心肌病合并心律失常40例[J].西部中医药,2018,31(12):92.
　LI Yaning,TAI Weiyan,WANG Jing,et al.YangXin DingJi Capsules in Treating 40 Cases of Dilated Cardiomyopathy Accompanying Arrhythmia[J].Western Journal of Traditional Chinese Medicine,2018,31(02):92.
[9]马路遥,孙晓,任明.基于荟萃分析探讨稳心颗粒治疗冠心病心律失常的药物经济学研究[J].西部中医药,2026,39(01):59.[doi:10.12174/j.issn.2096-9600.2026.01.12]
　MA Luyao,SUN Xiao,REN Ming.Meta-analysis Based Pharmacoeconomics of Wenxin Granules in Treating Arrhythmia in Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2026,39(02):59.[doi:10.12174/j.issn.2096-9600.2026.01.12]
[10]胡芳晓,杨传华,杨洁.基于血脉理论辨治靶向药物所致心律失常[J].西部中医药,2026,39(03):50.[doi:10.12174/j.issn.2096-9600.2026.03.11]
　HU Fangxiao,YANG Chuanhua,YANG Jie.Targeted Drug-induced Arrhythmias Differentiation Based on Blood Vessel Theory[J].Western Journal of Traditional Chinese Medicine,2026,39(02):50.[doi:10.12174/j.issn.2096-9600.2026.03.11]
[11]田伟,张大炜,李腾飞,等.左束支区域起搏术后缓慢性心律失常患者中医证候变化的研究[J].西部中医药,2023,36(04):89.[doi:10.12174/j.issn.2096-9600.2023.04.20]
　TIAN Wei,ZHANG Dawei,LI Tengfei,et al.The Study on the Changes of TCM Syndromes of Bradyarrhythmia Patients after Left Bundle Branch Pacing[J].Western Journal of Traditional Chinese Medicine,2023,36(02):89.[doi:10.12174/j.issn.2096-9600.2023.04.20]

备注/Memo

备注/Memo:
马春丽（1994—），女，硕士学位，医师。研究方向：腧穴配伍的理论与临床应用研究及针药并用治未病。山东省中医药科技发展计划项目（2017-023）。
更新日期/Last Update: 2024-02-15